Phase 3 Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have had migraines (with or without aura) for at least 6 months before the screening appointment.
- You have had between 1 and 8 moderate or severe migraine attacks per month in the 2 months before screening.
- You had at least 1 migraine day that needed treatment during the observation period of the study.
- If you are already taking medication to prevent migraines, the dose has stayed the same for at least 12 weeks before the screening appointment.
- You are able to tell the difference between a migraine and other types of headaches.
- You weigh more than 15 kg (for participants in EU countries aged 12 to under 18, you must weigh more than 25 kg).
- You have suitable veins that allow blood to be taken for testing.
- You are between 6 and 17 years old (you must not have turned 18 by the time of the baseline visit).
Who may not be able to join:
- You have a history of cluster headaches or a specific type of migraine called hemiplegic migraine.
- You have another significant pain condition that could interfere with the study results (confirm with trial site).
- You have a current psychiatric (mental health) condition that has not been properly treated or controlled for at least 6 months, or you have a lifetime history of psychosis or mania.
- You have a history of suicidal behaviour or are considered at risk of harming yourself or others.
- You have a history of a major psychiatric (mental health) disorder.
- You currently have or have had a history of substance abuse.
- You are currently using, or tested positive at screening for, drugs of abuse.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The frequency and severity of on-treatment and treatment-emergent adverse events, serious adverse events, adverse events leading to discontinuation, clinically significant lab abnormalities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.